| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/11/2009 | EP2022856A2 Improvements in or relating to binding proteins for recognition of DNA |
| 02/11/2009 | EP2022800A2 Compositions for the therapy and diagnosis of ovarian cancer |
| 02/11/2009 | EP2022799A2 Polycistronic expression of antibodies |
| 02/11/2009 | EP2022785A1 Alkynylpyrimidines as Tie2 kinase inhibitors |
| 02/11/2009 | EP2022775A2 Trihydroxy polyunsaturated eicosanoids |
| 02/11/2009 | EP2022500A1 Tumor suppressor |
| 02/11/2009 | EP2022498A2 Neuroendocrine tumour treatment |
| 02/11/2009 | EP2022492A1 Anti-cancer pharmaceutical composition |
| 02/11/2009 | EP2021372A2 Compositions and methods for modulating immune responses |
| 02/11/2009 | EP2021370A1 Trail receptor-binding agents and uses of the same |
| 02/11/2009 | EP2021338A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof |
| 02/11/2009 | EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 02/11/2009 | EP2021329A1 Inhibitors of c-fms kinase |
| 02/11/2009 | EP2021320A2 2-substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 02/11/2009 | EP2021316A1 Inhibitors of polo-like kinases |
| 02/11/2009 | EP2021032A1 Peg-modified arginine/lysine oxidoreductase |
| 02/11/2009 | EP2020998A1 Compositions and methods for the inhibition of endothelial nitric oxide synthase activity |
| 02/11/2009 | EP2020997A2 Novel actives against prostate carcinoma |
| 02/11/2009 | EP2020996A2 Method and compositions for treating hematological malignancies |
| 02/11/2009 | EP1851217B1 Substituted pyrido[2,3-d]pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders |
| 02/11/2009 | EP1748792B1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/11/2009 | EP1685134B1 Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents |
| 02/11/2009 | EP1487484B1 Use of mixtures of lipopeptides for vaccine production |
| 02/11/2009 | EP1480687B1 Modified phosphocalcic compound, injectable composition containing same |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | EP1259536B1 Methods of peptide preparation |
| 02/11/2009 | EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/11/2009 | CN101365799A Method for preparing antibodies selective for activating Fc receptors |
| 02/11/2009 | CN101365723A Antibodies directed to her-3 and uses thereof |
| 02/11/2009 | CN101365704A Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib |
| 02/11/2009 | CN101365703A Heteroalkyl linked pyrimidine derivatives |
| 02/11/2009 | CN101365701A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 02/11/2009 | CN101365700A Azaindazoles useful as inhibitors of kinases |
| 02/11/2009 | CN101365695A Quinazoline derivatives as anticancer agents |
| 02/11/2009 | CN101365674A Interleukin-1 and tumor necrosis factor-a modulators, syntheses of such modulators and methods of using such modulators |
| 02/11/2009 | CN101365486A Combination therapy using anti-EGFR and anti-HER2 antibodies |
| 02/11/2009 | CN101365473A Pharmaceutical composition for treating or preventing ovarian cancer |
| 02/11/2009 | CN101365449A Nanoparticulate benzothiophene formulations |
| 02/11/2009 | CN101365431A Novel use of nutraceutical compositions comprising resveratrol |
| 02/11/2009 | CN101365421A Substance for restoring normal co-expression and interaction between LOX and NRAGE proteins |
| 02/11/2009 | CN101363027A Method for preparing recombination plasmid carrying short hairpin RNA and use |
| 02/11/2009 | CN101362790A Starfish saponins antineoplastic compounds |
| 02/11/2009 | CN101362784A Ebomycin glycosides compounds, composition using the same as activity component and use thereof |
| 02/11/2009 | CN101362771A Method for preparing high purity vincristine sulfate |
| 02/11/2009 | CN101362745A Xanthenes compounds, preparation method and application thereof in antitumor |
| 02/11/2009 | CN101362736A Benzenesulfonamides Ca-4 analogue, synthesis method and application |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101362723A 2,4-diamino quinazolines compounds and synthesis method thereof |
| 02/11/2009 | CN101362719A Chinolines derivates and composition containing thereof |
| 02/11/2009 | CN101362718A 4-(4-benzamido phenoxy)-2-(methylcarbamoyl) pyridine derivatives, preparation method and application thereof |
| 02/11/2009 | CN101362717A 4-(4-amidoanilino)-2-(methylcarbamoyl) pyridine, derivates thereof and preparation, application thereof |
| 02/11/2009 | CN101362702A Emodin derivates and application thereof in anti-cancer medicine preparation |
| 02/11/2009 | CN101362679A Antrodia camphoratea pimelie kelone compound for inhibiting B type hepatitis virus |
| 02/11/2009 | CN101361983A Lung cancer DNA plasmid vaccine and preparation method thereof |
| 02/11/2009 | CN101361982A Preparation method of folacin coupled chitosan |
| 02/11/2009 | CN101361981A Preparation method of nano material suitable for infrared-light targeted therapy of cancer |
| 02/11/2009 | CN101361980A Heparin phospholipid composite suitable for non-injection administration and preparation method thereof |
| 02/11/2009 | CN101361978A Anti-cancer medicine release system using cellular membrane biomimetic modification polyamide-amide as carrier and preparation method thereof |
| 02/11/2009 | CN101361965A Use of vasodilator-stimulated phosphoprotein in preparing medicine for preventing and treating tumour in digestive system |
| 02/11/2009 | CN101361964A Use of vasodilator-stimulated phosphoprotein in preparing medicine for preventing and treating lung cancer and breast cancer |
| 02/11/2009 | CN101361947A Traditional Chinese medicine formulation for treating synovial sarcoma |
| 02/11/2009 | CN101361939A Malignant tumor treating medicine |
| 02/11/2009 | CN101361914A Traditional Chinese medicine formulation for treating oral cancer |
| 02/11/2009 | CN101361899A Traditional Chinese medicine formulation for treating lung cancer |
| 02/11/2009 | CN101361871A Formulation for treating rectum cancer and cervical carcinoma and preparation method thereof |
| 02/11/2009 | CN101361775A Traditional Chinese medicine freeze-dried injection for treating liver cancer |
| 02/11/2009 | CN101361771A Compound paclitaxel-oleum fructus bruceae injection emulsion and preparation method thereof |
| 02/11/2009 | CN101361749A Steroid saponin compound and use thereof in preparing anti-tumor medicine |
| 02/11/2009 | CN101361747A Adriablastina freeze-drying preparation with stable albumin and use thereof in treating tumor |
| 02/11/2009 | CN101361746A Stable adriablastina albumin lipid drug-loading system and preparation method thereof |
| 02/11/2009 | CN101361741A New anti-tumor use of iso-oxazoline derivates |
| 02/11/2009 | CN101361732A Medicinal preparation containing garcinia acid and use thereof |
| 02/11/2009 | CN101361731A Docetaxel freeze-drying preparation with stable albumin and use thereof in treating tumor |
| 02/11/2009 | CN101361730A Use of propofol succinic acid monoester sodium salt in preparing anti-tumor medicine |
| 02/11/2009 | CN101361714A Vincristine-reversal agent composite nano-granule and preparation method and use thereof |
| 02/11/2009 | CN101361713A Curcumin nano crystallization preparation and preparation method thereof |
| 02/11/2009 | CN101361712A Blood vessel target liposome carrier mediated by fiber forming growth factor receptor and preparation method and use thereof |
| 02/11/2009 | CN101361711A Dihydroartemisinin emulsion for injection, freeze-dried emulsion and preparation method thereof |
| 02/11/2009 | CN101361710A Anticancer composition containing tuomatinib |
| 02/11/2009 | CN101361705A Anti-cancer sustained release injection containing hexa-decyl choline phosphate |
| 02/11/2009 | CN101361704A Double sustained release gel injection |
| 02/11/2009 | CN100460412C Process for preparing amine platinum complexes |
| 02/11/2009 | CN100460397C Sulfur-containing quinoxaline dioxide, method for producing same and their application in preparing low-oxygen selective anti-tumor medicament |
| 02/11/2009 | CN100460395C Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
| 02/11/2009 | CN100460018C Polybutylcyanoacrylate nano-granule with resolubity, application and use thereof |
| 02/11/2009 | CN100460008C Chinese medicine composition for treating cancer |
| 02/11/2009 | CN100460002C Chinese medicine composition for treating various kinds of inflammation and cyst |
| 02/11/2009 | CN100459984C Medicinal composition for pet care and preparing method thereof |
| 02/11/2009 | CN100459983C Method for preparing soft capsule of ground bettle |
| 02/11/2009 | CN100459982C Dispersible tablet of doxifluridine |
| 02/11/2009 | CN100459976C Compound paclitaxel preparation containing phospholipid dispersant and preparation method thereof |
| 02/11/2009 | CN100459973C External-use ointment and preparing method thereof |
| 02/10/2009 | US7488825 mixing irinotecan with one or more solvents; adding hydrochloric acid to the mixture to form crystals; and collecting the formed crystals; crystals are present in the form of sesquihydrates |
| 02/10/2009 | US7488822 Cyclocarbamate derivatives as progesterone receptor modulators |
| 02/10/2009 | US7488815 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488798 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics |
| 02/10/2009 | US7488791 capable of stimulating the production of anti-HPV T CD4+ lymphocytes for vaccination against uterine of uterus cancer or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients |
| 02/10/2009 | US7488734 Anticancer agents; hormone replacement therapy; contraceptives |
| 02/10/2009 | US7488712 Histone deacetylase inhibitors and methods for producing the same |